Healthpeak Properties (DOC) Stock: Buy, Sell, or Hold?
DOC - Healthpeak Properties, Inc.
$20.30
-0.07 (-0.34%)
▼
5d:
-3.47%
30d:
-1.74%
90d:
-0.98%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 22, 2026
Get Alerted When DOC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DOC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DOC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: DOC is currently trading at $20.30, which is considered oversold relative to its 30-day fair value range of $20.54 to $21.43. From a valuation perspective, the stock is trading at a premium (Forward PE: 145.0) compared to its historical average (99.7). At these levels, the market is pricing in 13.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DOC is in a strong uptrend. The price is currently testing key support at $20.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DOC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.05 (+13.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DOC is in a strong uptrend. The price is currently testing key support at $20.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DOC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.05 (+13.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.54 -
$21.43
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($23.05)
- NEUTRAL: Trading at premium valuation - market expects 13.3% growth which is achievable
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$20.54 -
$21.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$20.20
Resistance Level
$21.37
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
145.00
Wall Street Target
$23.05
(+13.6%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
68.2%
Profit Margin
8.2%
Valuation Premium vs History
+13.3% premium
PE vs Historical
145.0 vs 99.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+13.3%
(market-implied from PE analysis)
1-Year Target
$23.00
(+13%)
2-Year Target
$26.06
(+28%)
3-Year Target
$29.52
(+45%)
3-Yr Target (if PE normalizes)
(PE: 145→100)
PE COMPRESSION
$20.30
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 145.0, Growth: 55.6%)
$68.51
(+238%)
Base:
(SPY PE: 20.2, Growth: 55.6%)
$9.53
(-53%)
Bear:
(PE: 17.1, Growth: 55.6%)
$8.10
(-60%)
📈
Valuation based on Current Earnings
Trailing PE: 58.20 | Current EPS (TTM): $0.35
Bull Case
$11.20
(-45%)
Analyst growth -50.0%, PE expands to 64.0
Base Case
$10.19
(-50%)
Market implied -50.0%, PE stable at 58.2
Bear Case
$13.85
(-32%)
Severe decline -20.0%, PE contracts to 49.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 2:43 AM ET
Data refreshes hourly during market hours. Next update: 3:43 AM
Data refreshes hourly during market hours. Next update: 3:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$102 | 57 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$262 | 54 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$16 | 60 HOLD |
|
OHI
Omega Healthcare Investo… |
HOLD
16 analysts |
$52 | 61 BUY |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
9 analysts |
$45 | 59 HOLD |
